NHS Commissioning and Access Policy
Cross-source consensus on NHS Commissioning and Access Policy from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Background
Evidence quality
Highlighted claims
- The clinical effectiveness of surgical correction for severe pectus excavatum is widely contested among clinicians, commissioners, and payers. — Surgery versus conservative management for severe pectus excavatum (RESTORE): protocol for a multicentre, randomised, controlled superiority trial
- NHS England decommissioned pectus excavatum surgery in 2019, citing the absence of high-quality comparative data demonstrating physical or cardiopulmonary benefit. — Surgery versus conservative management for severe pectus excavatum (RESTORE): protocol for a multicentre, randomised, controlled superiority trial
- Pectus excavatum surgery was reinstated in England but restricted to the most severe cases verified by a national multidisciplinary team. — Surgery versus conservative management for severe pectus excavatum (RESTORE): protocol for a multicentre, randomised, controlled superiority trial
- Patients who cannot safely wait 12 months for treatment, as determined by a national MDT, are enrolled in a parallel observational cohort rather than the RCT. — Surgery versus conservative management for severe pectus excavatum (RESTORE): protocol for a multicentre, randomised, controlled superiority trial